Page 2 - Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Aug 16, 2025

Discover large cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

114 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1952
Everest Medicines
HK$70.60-1.0%256.9%HK$24.8bHK$55.53PS32.2xE108.5%n/a
2162
Keymed Biosciences
HK$73.908.4%132.0%HK$21.8bHK$63.71PS46.7xE31.4%n/a
2617
TransThera Sciences (Nanjing)
HK$50.5015.1%n/aHK$20.0bn/aPB35xn/an/a
2627
Ab&B Bio-Tech JS
HK$47.18n/an/aHK$18.6bn/aPS65.6xn/an/a
2157
Lepu Biopharma
HK$9.767.3%226.4%HK$17.6bn/aPS43.9xn/an/a
6185
CanSino Biologics
HK$50.301.7%154.3%HK$17.2bHK$43.15PS13.1xE107.5%0%
1672
Ascletis Pharma
HK$17.7429.7%2,037.3%HK$17.1bHK$14.71PS6630.1xE9.2%n/a
2186
Luye Pharma Group
HK$3.80-2.1%30.6%HK$14.4bHK$2.79PE28xE21.6%0%
2616
CStone Pharmaceuticals
HK$9.2832.6%603.0%HK$13.6bHK$6.56PS61.6xE94.5%n/a
9887
Nanjing Leads Biolabs
HK$69.350.9%n/aHK$13.4bn/aPB63.9xn/an/a
460
Sihuan Pharmaceutical Holdings Group
HK$1.433.6%164.8%HK$13.1bn/aPS6.3xn/a0%
2171
CARsgen Therapeutics Holdings
HK$22.7013.4%457.7%HK$12.6bHK$22.64PS137.3xE118.2%n/a
6826
Shanghai Haohai Biological Technology
HK$29.220.9%1.8%HK$12.6bHK$42.64PE14.8xE12.9%4.5%
2565
PegBio
HK$32.0094.5%n/aHK$12.4bn/aPB217.1xn/an/a
2629
Mirxes Holding
HK$44.2234.6%n/aHK$11.6bn/aPS73.3xn/an/a
570
China Traditional Chinese Medicine Holdings
HK$2.282.2%-44.5%HK$11.5bHK$1.60PE194.9xS1.9%0.2%
1681
Consun Pharmaceutical Group
HK$13.32-2.1%135.8%HK$11.0bHK$11.95PE11.1xE11.6%4.5%
2256
Abbisko Cayman
HK$16.0030.1%421.2%HK$10.8bHK$15.19PE65.9xE-107.5%n/a
719
Shandong Xinhua Pharmaceutical
HK$8.041.3%45.4%HK$10.4bn/aPE11.6xS6.7%3.7%
6955
Shandong Boan Biotechnology
HK$16.26-11.6%80.9%HK$10.1bHK$10.44PE126.9xS27.4%n/a
2315
Biocytogen Pharmaceuticals (Beijing)
HK$24.642.7%268.3%HK$9.8bn/aPE269.2xn/an/a
2142
HBM Holdings
HK$12.1917.2%867.5%HK$9.7bHK$12.07PE444.7xE32.8%n/a
1349
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$4.01-0.2%115.6%HK$9.4bn/aPS5.5xn/a1.6%
775
CK Life Sciences Int'l. (Holdings)
HK$0.97-3.0%185.3%HK$9.3bn/aPS1.7xn/a0%
Page 2 of 5